Filing Details
- Accession Number:
- 0001209191-17-059597
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-07 16:16:21
- Reporting Period:
- 2017-11-03
- Accepted Time:
- 2017-11-07 16:16:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1099219 | Metlife Inc | MET | Life Insurance (6311) | 134075851 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1555359 | G Christopher Townsend | Level 20, Cityplaza 3 14 Taikoo Wan Road Taikoo Shing K3 00000 | President, Asia | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-11-03 | 49,660 | $27.19 | 49,660 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-03 | 49,660 | $54.61 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2017-11-03 | 33,071 | $31.15 | 33,071 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-03 | 33,071 | $54.60 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2017-11-03 | 49,660 | $0.00 | 49,660 | $27.19 |
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2017-11-03 | 33,071 | $0.00 | 33,071 | $31.15 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2022-07-31 | No | 4 | M | Direct | |
0 | 2023-02-25 | No | 4 | M | Direct |
Footnotes
- The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The Reporting Person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
- The shares were sold in multiple transactions at prices $54.560 to $54.630, inclusive.
- The shares were sold in multiple transactions at prices $54.600 to $54.618, inclusive.
- The options became exercisable in three equal installments on August 1, 2013, 2014 and 2015.
- The options became exercisable in three equal installments on February 26, 2014, 2015 and 2016.